Zobrazeno 1 - 10
of 1 546
pro vyhledávání: '"Racadot E"'
Publikováno v:
In Journal Francais d'Ophtalmologie January 2013 36(1):5-11
Autor:
Lapierre, V., Pellegrini, N., Bardey, I., Malugani, C., Saas, P., Garnache, F., Racadot, E., Maddens, S., Schillinger, F.
Publikováno v:
In Cytotherapy 2007 9(2):165-169
Publikováno v:
In La Revue de médecine interne 2002 23(8):696-702
Autor:
Fang, William H.1 (AUTHOR) william.fang@uhsinc.com, Vangsness Jr., C. Thomas2 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6577. 18p.
Autor:
Naji, A., Deschaseaux, F., Racadot, E., Ferrand, C., Justrabo, E., Guignier, F., Mousson, C., Rifle, G.
Publikováno v:
In Transplantation Proceedings 2005 37(6):2892-2893
Autor:
Pierre Tiberghien, P. Herve, M. Deschaseaux, L. Voillat, E. Deconinck, Racadot E, S. Comparot, J. Vuillier, J.M. Cordonnier, J. Fontan, Marie-Christine Woronoff-Lemsi, J.Y. Cahn, P Morel, Régis Angonin, Annie Brion
Publikováno v:
Hematology and cell therapy. 41(2)
T-cell depletion (TCD) of the bone marrow graft remains the most effective method to prevent severe graft versus host disease after allogeneic bone marrow transplantation. Early studies of HLA-identical sibling transplants showed that although T-cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::260444ab24adffa69a9f120a7e28a292
https://pubmed.ncbi.nlm.nih.gov/10344550
https://pubmed.ncbi.nlm.nih.gov/10344550
Autor:
Wendling D, Racadot E, Wijdenes J, Jean Sibilia, Rm, Flipo, Cantagrel A, Miossec P, Jp, Eschard, Macro M, Bertin P, Lioté F, Debiais F, Juvin R, Le Goff P, Masson C
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
To assess safety and efficacy of a murine anti-CD4 monoclonal antibody (Mab) in a population of patients with rheumatoid arthritis (RA) compared to treatment with placebo.Fifty-eight patients with defined RA were included in this placebo controlled,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f700659b70c5d9f5abeb3dad66b76e1b
https://pubmed.ncbi.nlm.nih.gov/9712083
https://pubmed.ncbi.nlm.nih.gov/9712083
Autor:
Sunar Yayla, Emine Nur1,2 enursunar@hotmail.com, Yıldız, Çisem1, Şenol, Pelin Esmeray1, Karaçayır, Nihal1, Yıldırım, Deniz Gezgin1, Bakkaloğlu, Sevcan A.1
Publikováno v:
Turkish Archives of Pediatrics. Mar2024, Vol. 59 Issue 2, p185-192. 8p.
Autor:
Ahmadi, Maryam1, Soleimanifar, Narjes2, Rostamian, Abdolrahman3, Sadr, Maryam2, Mojtahedi, Hanieh2, Mazari, Abeda1, Nicknam, Mohammad Hossein1,2, Assadiasl, Sara2 saraasadiasl@gmail.com
Publikováno v:
Archives of Rheumatology. Mar2024, Vol. 39 Issue 1, p123-132. 10p.
Autor:
John Wijdenes, J.F. Bonneville, Izzie Jacques Namer, Jacques Chambron, Racadot E, Christian Marescaux, Jean-Paul Armspach, Lucien Rumbach, Herve P
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 1(4)
An initial group of 21 patients plus a second group of 14 patients with active multiple sclerosis (MS) (18 progressive and 17 relapsing-remitting forms) were treated with a murine monoclonal anti-T CD4/BF5 antibody as part of a phase 1 open trial. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac308cd043f7a7c50ad7685e67adad9
https://pubmed.ncbi.nlm.nih.gov/9345436
https://pubmed.ncbi.nlm.nih.gov/9345436